Derek J. Theisen

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Stephen T. Ferris, Vivek Durai, Renee Wu et al. · Nature · 2020 · 537 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, T-regulatory Cell +14

WDFY4 is required for cross-presentation in response to viral and tumor antigens

Derek J. Theisen, Jesse T. Davidson, Carlos G. Briseño et al. · Science · 2018 · 327 citations · Full text

Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells

Carlos G. Briseño, Malay Haldar, Nicole M. Kretzer et al. · Cell Reports · 2016 · 200 citations · Full text

Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity

Dania Zhivaki, Francesco Borriello, Ohn A. Chow et al. · Cell Reports · 2020 · 152 citations · Full text

Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections

Larissa B. Thackray, Scott A. Handley, Matthew J. Gorman et al. · Cell Reports · 2018 · 128 citations · Full text

Disease Severity, Pathogenesis, Immunology +12